Grant: Idea to Innovation
University of Waterloo
$20,000.00
L2M NSERC - Integrated Microfluidic Electrochemical Assay for Cervical Cancer Detection at Point-of-Care Testing
FY 2022-23
Summary
Cervical Cancer (CC) is a curable disease, yet it kills about 311000 women yearly in low- and middle-income countries (LMIC) due to lack of screening and treatment. CC; if detected early, can successfully be treated. However, limited access to prevention, screening, and treatment contributes to 90% of the CC-associated deaths. Current techniques used for CC screening in developed countries are relatively expensive while also requiring sophisticated equipment and trained professionals, none of which is easily accessible in LMIC. We have developed an automated, cost-effective, and portable device that can screen women for CC. Our device consists of two main modules: i) a microfluidic part for sample processing, and ii) an electrochemical biosensor for target identification. We have characterized the accuracy of our device in the lab and with spiked samples. We believe our device has the potential to transform CC detection and screening at remote locations.
Program
Idea to Innovation
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
576535-2022
Name nom
Poudineh, Mahla MP
Department département
Electrical & Computer Engineering
Organization id
33
Institution établissement
University of Waterloo
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2022
Competition year année de concours
2022
Award amount
20000
Program id
I2IPJ
Program name en
Idea to Innovation
Program name fr
De l'idée à l'innovation
Group en
RESEARCH PARTNERSHIPS
Group fr
PARTENARIATS DE RECHERCHE
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
9999
Area of application group en
Not available
Area of application group fr
Non disponible
Area of application en
Not available
Area of application fr
Non disponible
Research subject code
1900
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical engineering
Research subject fr
Génie biomédical
Installment
inst:1
Partie
1
Nb partie
1
Application title
L2M NSERC - Integrated Microfluidic Electrochemical Assay for Cervical Cancer Detection at Point-of-Care Testing
Application summary
Cervical Cancer (CC) is a curable disease, yet it kills about 311000 women yearly in low- and middle-income countries (LMIC) due to lack of screening and treatment. CC; if detected early, can successfully be treated. However, limited access to prevention, screening, and treatment contributes to 90% of the CC-associated deaths. Current techniques used for CC screening in developed countries are relatively expensive while also requiring sophisticated equipment and trained professionals, none of which is easily accessible in LMIC. We have developed an automated, cost-effective, and portable device that can screen women for CC. Our device consists of two main modules: i) a microfluidic part for sample processing, and ii) an electrochemical biosensor for target identification. We have characterized the accuracy of our device in the lab and with spiked samples. We believe our device has the potential to transform CC detection and screening at remote locations.